8-K: Aclaris Therapeutics, Inc. — Item 1.01 Entry into a Material Definitive Agreement
Filed: 2026-10-27 AccNo: 0001104659-26-119231 Size: 688 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibi
Filed: 2026-10-27 AccNo: 0001104659-26-119231 Size: 688 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibi